Success Metrics

Clinical Success Rate
95.0%

Based on 19 completed trials

Completion Rate
95%(19/20)
Active Trials
2(8%)
Results Posted
32%(6 trials)
Terminated
1(4%)

Phase Distribution

Ph phase_2
1
4%
Ph phase_3
4
16%
Ph not_applicable
14
56%
Ph phase_1
5
20%

Phase Distribution

5

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution24 total trials
Phase 1Safety & dosage
5(20.8%)
Phase 2Efficacy & side effects
1(4.2%)
Phase 3Large-scale testing
4(16.7%)
N/ANon-phased studies
14(58.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.5%

19 of 21 finished

Non-Completion Rate

9.5%

2 ended early

Currently Active

2

trials recruiting

Total Trials

25

all time

Status Distribution
Active(2)
Completed(19)
Terminated(2)
Other(2)

Detailed Status

Completed19
Recruiting2
unknown2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
2
Success Rate
95.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (20.8%)
Phase 21 (4.2%)
Phase 34 (16.7%)
N/A14 (58.3%)

Trials by Status

recruiting28%
completed1976%
terminated14%
withdrawn14%
unknown28%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT06716398Not Applicable

A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase

Recruiting
NCT03315221Phase 2

Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants.

Completed
NCT06446063

Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.

Recruiting
NCT06300905Phase 3

Clinical Study on Malodor

Completed
NCT06126042Phase 1

Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route

Unknown
NCT05370196Not Applicable

Synthetic Male Condom Slippage-Breakage Study

Completed
NCT05372900Not Applicable

Nutritional Intervention to Improve Sleep Quality and Improve Next-day Mood and Cognitive Benefits

Completed
NCT01609634Not Applicable

New Infant Formula Trial in Healthy Term Subjects on Growth, Body Composition, Tolerance and Safety

Completed
NCT04811157Not Applicable

The Effect of Functional Dairy Products Enriched With Dietary Fibers on Human Health and Gut Microbiota

Completed
NCT04466176Phase 1

A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Completed
NCT04051710Phase 3

Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH

Completed
NCT03093181Not Applicable

A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin

Completed
NCT03562949Phase 3

A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol

Terminated
NCT03975166Phase 1

A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 Inhalation Powder/GSK in Healthy Volunteers

Completed
NCT03197883Not Applicable

Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure

Completed
NCT03119688Not Applicable

To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT)

Completed
NCT03820180Phase 1

A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

Completed
NCT03037307Not Applicable

A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive

Completed
NCT03562923Phase 3

A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50

Unknown
NCT02551627Not Applicable

A Study to Investigate the Impact of a Multiple Micronutrient (MMN) Beverage Powder on Vaccine Response in School Children

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
25